FDA Approved: LOJAIMIESS — Supplemental Application (Xiromed LLC)

View source ↗

Summary

FDA approved a supplemental application for LOJAIMIESS, a combination oral contraceptive manufactured by Xiromed LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• LOJAIMIESS (LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS)

Snippet

SUPPL AP for LOJAIMIESS (LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL TABLETS)